Page Tools:

Hypertension and Dyslipidemia Management Essentials

Author(s): Robert Miller Guthrie, MD, Ohio State University
Details:
  • ISBN-13: 9780763759261
  • Paperback    136 pages      © 2010
Price: International Sales $57.95 US List
Add to Cart

Overview

An essential resource for all cardiologists, internists, and medical residents, Hypertension and Dyslipidemia Management Essentials assists clinicians in the treatment of hypertension and high cholesterol, the two most easily diagnosed and treatable risk factors for cardiovascular disease. This concise yet complete handbook includes the scientific background for each drug class presented, and includes a review of the science supporting the utilization of the agents in particular patient situations. The medications and their doses and dosage forms are presented in easy to use tables, so that the practitioners can quickly access the information to make their treatment decisions, whether they are in the hospital or in an outpatient setting.

ShowKey Features

  • The format is designed for quick and easy use in patient care situations, either in a hospital or outpatient setting.
  • The medications discussed are arranged in order of prominence, so that the commonly used agents are found first in the text.
  • There are very clear discussions of the major research projects that support the use of the various agents.
  • Tables at the back are readily available for quick and efficient use.
  • This text covers the treatment of both of the major risk factors for cardiovascular disease, hypertension and hyperlipidemia, that are seen in primary care practice.

 

 

Back to top

ShowTable of Contents

Section  1  Section 1: Hypertension
  Chapter  1  Hypertension
  Chapter  2  Hypertension Management
  Chapter  3  Diuretics
  Chapter  4  Angiotensin-Converting Enzyme Inhibitors-ACE Inhibitors
  Chapter  5  Calcium Channel Blockers
  Chapter  6  Angiotensin Receptor Blockers
  Chapter  7  Beta-Blockers
  Chapter  8  Alpha-1 Blockers
  Chapter  9  Renin Inhibitors
  Chapter  10  Aldosterone Receptor Blockers
  Chapter  11  Central Agonists
  Chapter  12  Direct Vasodilators
  Chapter  13  Peripheral Adrenergic Inhibitors
Section  2  Cholesterol
  Chapter  14  Hyperlipidemia
  Chapter  15  Diagnosis and Risk Stratification
  Chapter  16  Treatment Issues
  Chapter  17  Other Diagnostic Modalities
  Chapter  18  HMG-CoA Reductase Inhibitors (Statins)
  Chapter  19  Ezetimibe
  Chapter  20  The Fibrates (Fibric Acid Derivatives)
  Chapter  21  Niacin
  Chapter  22  Bile Acid Sequestrates
  Chapter  23  Omega-3 Fish Oils
  Chapter  24  Torcetrapib
  Chapter  25  Coenzyme Q10
Back to top

ShowAbout the Author(s)

Robert Miller Guthrie, MD-Ohio State University

Dr Guthrie is 1974 graduate of the University of Maryland School of Medicine, and he is residency trained and Board Certified in both Family Medicine and Internal Medicine. He is a Professor in the Department of  Emergency Medicine at the Ohio State University. At Ohio State University, Dr Guthrie conducts a Clinical Research Program focusing on the development of new pharmacological agents for use in the management of hypertension, hyperlipidemia, and diabetes. Dr Guthrie has authored over 175 papers, presented papers, and abstracts, and he has lectured extensively throughout the US on the prevention of cardiovascular disease.

Back to top